 The purpose of this study is to determine the safety and efficacy of long-term combination therapy with alogliptin Nesina and thiazolidinediones in patients with type 2 diabetes mellitus who failed to respond adequately to treatment with thiazolidinediones in addition to diet therapy and exercise therapy. 